Tecovirimat (TPOXX) is the first FDA approved drug treatment of smallpox. In 1980, WHO declared that smallpox was eradicated; however, tecovirimat was developed as a counter to the possible use of smallpox as a bio-weapon. It is the first product awarded a Material Threat Medical Countermeasure priority review voucher by the FDA.
- The Robot Will See You Now… How AI & Robotics are Transforming the Healthcare Industry
- From Meal Prep to Calorie Tracking: Key Nutritional Habits Worth Embracing
- Insulin’s Rising Costs: A Barrier to Diabetes Care
- Precision without Fatigue: Focusing on User-experience and Technology to Improve Patient Outcomes
- PEPID’s Founder and CEO Discusses the Challenges and Merits of PGx